|
|
![]() |
|||
|
Abstract Dr. Lindblom Nuclear Receptor Activation of Drug Metabolism Enzymes in C. elegans The long-term goal of this project is to determine the molecular factors that govern the endotoxin and xenobiotic induced regulation of drug metabolizing enzymes (DME) and corresponding transporters. The major biological model for this project is C. elegans, however, all accumulated data will be compared to vertebrate models including humans. In the past several years, the nuclear receptor (NR) SXR has been implicated as a key mediator in endotoxin and xenobiotic activation of cytochromes P450 (CYP) in many species. In collaboration with Dr. Ron Evans from the Salk Institute, we accumulated data which demonstrates that SXR is also a critical regulator of UDP-glucuronosyltransferase (UGT) gene expression and activation of this receptor correlates to UGT induction. Two facts suggest that NR regulation of detoxification protein expression is a broadly conserved NR function. First, we have demonstrated that a nematode member of the SXR subfamily of NRs, NHR-8, contributes to C. elegans xenobiotic resistance. Secondly, within the genome of C. elegans, we have identified 72 open reading frames that encode proteins similar to the mammalian UGTs. Based on this analysis, we will study NHR-8 regulation of UGT expression in this nematode model system. The central hypothesis is that NHR-8 regulates the expression of the nematode detoxification network in response to the presence of endogenous and xenobiotic toxic compounds in a manner similar to the vertebrate model. We will (1) discover the genes putatively regulated by NHR-8 utilizing DNA microarray analyses, (2) confirm NHR-8 target gene identify using a variety of experimental methods including RNA mediated interference and reporter gene expression, and (3) identify the cis regulatory sequences controlling nhr-8 expression. This research will generate the data we intend to utilize for the production of humanized nematode models for DME upregulation. Such a system would allow rapid and accurate analyses of drug modification and detoxification in a highly tractable and genetically amenable system. Further, this research lays the foundation for NHR-8 and vertebrate NR ligand discovery.
Updated 10/31/2005
The Arkansas INBRE is Supported by a grant from the
National Institutes of Health
Please contact Caroline Miller Robinson regarding questions or comments about this site or our program. For more information about the University of Arkansas for Medical Sciences visit http://www.uams.edu.
|
||||